awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q30378509-9134DEB8-8AFF-40D6-8163-2F5C354D3FCA
Q30378509-9134DEB8-8AFF-40D6-8163-2F5C354D3FCA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30378509-9134DEB8-8AFF-40D6-8163-2F5C354D3FCA
Hepatitis C treatment: where are we now?
P2860
Q30378509-9134DEB8-8AFF-40D6-8163-2F5C354D3FCA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30378509-9134DEB8-8AFF-40D6-8163-2F5C354D3FCA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1a076d2c1fc72b99764a5f69f11eb4e971ecfba9
P2860
Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial.